ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -8.3% | 4,000 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $12,000 | -25.0% | 4,000 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $16,000 | -5.9% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $17,000 | +41.7% | 4,000 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $12,000 | -7.7% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | -7.1% | 4,000 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $14,000 | +7.7% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $13,000 | +85.7% | 4,000 | 0.0% | 0.01% | +66.7% |
| Q2 2020 | $7,000 | +75.0% | 4,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $4,000 | -63.6% | 4,000 | 0.0% | 0.00% | -60.0% |
| Q4 2019 | $11,000 | +83.3% | 4,000 | 0.0% | 0.01% | +66.7% |
| Q3 2019 | $6,000 | -45.5% | 4,000 | +33.3% | 0.00% | -50.0% |
| Q1 2019 | $11,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
| RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
| Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
| Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
| ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
| PDT Partners, LLC | 66,965 | $489,000 | 0.02% |